GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2601 - 2625 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgG Patient 3 -180 mild
G61751GZ
49
IgM Patient 3 -180 mild
G61751GZ
94
IgA Patient 3 4 mild
G61751GZ
415
IgG Patient 3 11 mild
G61751GZ
41
IgG Patient 3 4 mild
G61751GZ
40
IgM Patient 3 11 mild
G61751GZ
114
IgM Patient 3 4 mild
G61751GZ
100
IgA Patient 4 12 mild
G61751GZ
425
IgG Patient 4 12 mild
G61751GZ
60
IgM Patient 4 12 mild
G61751GZ
136
IgA Patient 1 10 moderate
G62222PE
382
IgA Patient 1 22 moderate
G62222PE
364
IgA Patient 1 6 moderate
G62222PE
338
IgG Patient 1 10 moderate
G62222PE
83
IgG Patient 1 22 moderate
G62222PE
89
IgM Patient 1 10 moderate
G62222PE
50
IgM Patient 1 22 moderate
G62222PE
57
IgG Patient 1 6 moderate
G62222PE
43
IgM Patient 1 6 moderate
G62222PE
40
IgA Patient 2 15 mild
G62222PE
349
IgA Patient 2 24 mild
G62222PE
368
IgG Patient 2 15 mild
G62222PE
297
IgG Patient 2 24 mild
G62222PE
285
IgM Patient 2 15 mild
G62222PE
217
IgM Patient 2 24 mild
G62222PE
230

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024